ADAMAS PHARMACEUTICALS INC stock forecast: down to 7.78 USD ADMS stock price prognosis


Forecast for Wed 19 Jan 2022 price 6.50

ADAMAS PHARMACEUTICALS INC stock price forecast for further price development down to -5.39% (time horizon: 1 day) and price target of 7.78 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ADAMAS PHARMACEUTICALS INC share price prediction for 2022-01-19 with daily closed price projections

Key Facts

Symbol ADMS 

ISIN US00548A1060 

CUSIP 00548A106

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.33)

Finance numbers

Revenue 79,291,000.0

Earnings per share -1.80

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.

Summerized Form 10-K with GPT-2

We began recognizing royalties on net sales of NAMZARIC in May of 2020. We also own additional foreign patents and patent applications covering GOCOVRI. These patents expire as late as 2029 and are exclusively licensed to Allergan. These actions could have a material impact on the availability of our products. Submission of an IND may not result in FDA authorization to commence a clinical trial. Insurance coverage is increasingly expensive. We have recently settled an ANDA litigation with a generic filer. We do not independently conduct clinical studies of our products. In addition, we could be found liable for monetary damages. In addition, funds are required for the continued operation of our business. Our stock price has fluctuated in the past and may be volatile in the future.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 20.85/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is under book price value.

Institutional ownership list is based on filling form information

Holding name Date Amount
Engineers Gate Manager LP 2021-03-31 15995
Fisher Asset Management, LLC 2021-06-30 59771
Squarepoint Ops LLC 2021-03-31 57484

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2021-05-31 48934 Long
SPARROW FUNDS 2021-05-31 16885 Long
iShares U.S. ETF Trust 2021-04-30 506 Long
Fidelity Capital Trust 2021-04-30 1415648 Long
SCHWAB CAPITAL TRUST 2021-04-30 17873 Long


CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1717583 Prentiss Christopher B 2021-03-22 SALE Accept Accept Accept Accept
1778051 Shreedhar Vijay 2021-03-22 SALE Accept Accept Accept Accept

ADAMAS PHARMACEUTICALS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

On-Balance Volume information for ADAMAS PHARMACEUTICALS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for ADAMAS PHARMACEUTICALS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for ADAMAS PHARMACEUTICALS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for ADAMAS PHARMACEUTICALS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for ADAMAS PHARMACEUTICALS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for ADAMAS PHARMACEUTICALS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for ADAMAS PHARMACEUTICALS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2021-12-03 7.78 2021-11-24 03:48
2021-12-06 7.72 2021-11-24 03:48
2021-12-07 7.67 2021-11-24 03:48
2021-12-09 7.55 2021-11-24 03:48
2021-12-08 7.61 2021-11-24 03:48
2021-12-10 7.49 2021-11-24 03:48
2021-12-13 7.45 2021-11-24 03:48
2021-12-14 7.40 2021-11-24 03:48
2021-12-15 7.35 2021-11-24 03:48
2021-12-16 7.31 2021-11-24 03:48
2021-12-17 7.26 2021-11-24 03:48
2021-12-20 7.22 2021-11-24 03:48
2021-12-21 7.17 2021-11-24 03:48
2021-12-22 7.14 2021-11-24 03:48
2021-12-23 7.10 2021-11-24 03:48
2021-12-24 7.06 2021-11-24 03:48
2021-12-27 7.03 2021-11-24 03:48
2021-12-28 6.99 2021-11-24 03:48
2021-12-29 6.96 2021-11-24 03:48
2021-12-30 6.92 2021-11-24 03:48
2021-12-31 6.89 2021-11-24 03:48
2022-01-05 6.79 2021-11-24 03:48
2022-01-06 6.76 2021-11-24 03:48
2022-01-07 6.73 2021-11-24 03:48
2022-01-14 6.58 2021-11-24 03:48
2022-01-03 6.86 2021-11-24 03:48
2022-01-04 6.83 2021-11-24 03:48
2022-01-10 6.70 2021-11-24 03:48
2022-01-11 6.67 2021-11-24 03:48
2022-01-12 6.64 2021-11-24 03:48
2022-01-13 6.61 2021-11-24 03:48
2022-01-17 6.55 2021-11-24 03:48
2022-01-18 6.53 2021-11-24 03:48
2022-01-19 6.50 2021-11-24 03:48